Member Info for LeBadinho

Ask several times about that. They are still convinced to get to those numbers.
They had to evaluate what is the best product for the best area. Based on that they hopefully start ramping up the speed relating the network growth after AGM again.

If the statements of the management are to be believed, the company is liquid enough not to have to carry out another private placement or similar.

But we will all only be able to judge that at the end of the year, when the blood tests have hopefully shown that they can carry the company.

i think there will be some update on CBD during the AGM.
If those flying pigs could deliver CBD and Home test kits - why not ;D

@MPBUK: i think if than AIM

@Barravelli: I think GDBY will prefer a buying on the open market out of the left outstanding shares. No additional shares issued. Don't know how much percentage are possible. But thats are only thoughts from my side.

He guys, had some conversation last week with Anne. This week is pretty quiet. I think they are in deep preparation for the AGM.

From my perspective they should achieve those milestones until the end of the year to go in a succesful 2023:

- Reverse Split
- UK move
- De-Listing CAN
- UpListing UK
- (institutional investor)
- pharmacy network growth (min 450)

based on that, I again reached out to GDBY mentioning that lse.co.uk and hl.co.uk are providing News about companies by getting them from Sharecast.

Hopefully something will change after the move to Guernsey

well, to be honest - NO.
But what i heard HL was not the problem from GDBY side. It was more a technical issue from HL side.

And I'm still thinking all bricks are currently leading to the direction of an uplisting in UK.

- reducing share count
- moving to Guernsey
- increasing share availability in UK
....

In Germany, we do have a proverb for things like that:
"What's been a long time coming will finally be good." ;D

I just found out by surfing on goodbodyhealth.com that HL is now also possible. :D Finally!

https://www-proactiveinvestors-co-uk.cdn.ampproject.org/c/s/www.proactiveinvestors.co.uk/companies/amp/news/987979

If the NHS really decides to shift blood testing to private companies the potential of possible bloodtests will immediately increase from 60mio to 600mio tests per year in the UK.

it's goodbodyclinic and goodbody.store
:D

i don't know if all of you are following Goodbody on Instagram. They are currently rolling out their Home Test Kits to all of their pharmacy locations to also increase the upselling of those products right at the point of sale.

I think so. They must be shared latest end of August. But i think there will be more important things announce before that. Because all of us should be aware that the Q2 fins will not be nearly the same like the full covid Q1 revs.

Hi everyone,

today I had the opportunity to talk to Marc, George, Anne and Cassie (Director of Clinic Marketing) about marketing for an hour today. It was extremely technical as I come from a marketing background myself.

The bottom line is that Cassie has a ton of clue.

They have already activated some measures to increase direct clinic sales. Some things are still in the pipeline. Budgets are used specifically to reach target groups better and more precisely in order to increase sales to the maximum of the investment.

B2B (pharmacies, doctors, partners) and B2C (customers and patients) - more than adequately covered.

With B2S (shareholders) there is currently the difficulty of "high" costs, as news always has to be produced for two markets and PR is paid for both. With the move to the UK and the de-listing in CAN, this will simplify the structure and the money can then be used more efficiently. There is already a detailed plan of what will be done in this area immediately after de-listing and moving to UK.

Without them clearly stating it - because they are not allowed to - my nose tells me that it smells like an uplisting in the UK, coupled with the RS.

i think there are no further capital raises necessary. From my perspective the following scenario will happen:

- De-Listing Canada
- moving to UK to get a GB-ISIN
- consolidation
- Institutional Investor buying from the open market
- up-listing in UK
(- buyback of some shares if it is still cheap in Q1 2023)

maybe not in that order but i think that's what is going to happen ;D

I think it will. There is a lot of stuff in back going on in direct relation to the move to UK. Let's wait until this is done.

i don't know what it is about and what will happen after that. What you can do is participate on the AGM and raise your questions there.

well, if you are currently f.e. holding 100.000 shares at 0,01p now, you will have 10.000 shares at 0,10p after the RS.

it is something which is really necessary. Make the RS 10 to 1. Hopefully they can prove the success of the blood tests until the RS is done. Otherwise it could be difficult for the SP.

To be honest, I think there will be no movement OR negative movement of the SP until it is done when there are no big news in between (f.e. finalize de-listing CAN; onbaord an institutional investor; making bigger progress on the clinic network growth)....

Theoretically they can already de-list.

Maybe they will do it together with the voting from the AGM on 8th of August where the moving to Guernsey will hopefully be applied. As I heard it will maybe take 2-4 weeks to get it fully done.

he guys, its pretty quiet. Anne has been on vacation the last week. I asked for updates on the clinic network rollout, CQC progress and maybe again increasing covid testing revs.